Lab
Central Clinical Labs, INC
Central Clinical Labs, INC was paid $9.71M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 53% of everything it billed.
33Billing provider infoCENTRAL CLINICAL LABS, INC
CHICAGO, IL 60638
CHICAGO, IL 60638
33aNPI1447345830assigned 10/03/2006
33bProvider typeClinical Medical Laboratory
28Total paid$9.71M
24GClaims553,945
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Illinois
Rank by total paid#18 of 235
Median peer was paid$123K
This provider vs. median79×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69,983 | $465K | |
| 2019 | 113,412 | $1.18M | |
| 2020 | 109,352 | $2.55M | |
| 2021 | 100,202 | $3.03M | |
| 2022 | 70,246 | $1.86M | |
| 2023 | 46,713 | $354K | |
| 2024incomplete | 44,037 | $264K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 53% | 72,318 | 22,230 | $5.10M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.2% | 38,323 | 13,903 | $793K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 6.3% | 1,993 | 1,340 | $612K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 4.4% | 21,206 | 7,044 | $426K |
| 80053 | Comprehensive metabolic panel | 3.5% | 43,060 | 26,766 | $340K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 59,079 | 35,003 | $284K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 1.8% | 78,025 | 29,286 | $174K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 1.8% | 12,101 | 6,058 | $173K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.7% | 12,527 | 9,780 | $166K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,252 | 945 | $87K |
| 86481 | <1% | 1,834 | 1,647 | $80K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,148 | 8,099 | $76K |
108 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,710 | $73K |
| 87481 | <1% | 1,303 | $71K | |
| 80061 | Lipid panel | <1% | 14,669 | $64K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,335 | $57K |
| 87640 | <1% | 1,663 | $55K | |
| 87653 | <1% | 1,660 | $55K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,937 | $53K |
| 82607 | <1% | 4,870 | $48K | |
| 87505 | <1% | 622 | $47K | |
| 82746 | <1% | 4,908 | $46K | |
| 87186 | <1% | 3,957 | $44K | |
| 83721 | <1% | 7,333 | $42K | |
| 86480 | <1% | 1,730 | $41K | |
| 85610 | <1% | 12,416 | $40K | |
| 87500 | <1% | 1,886 | $40K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 145 | $39K |
| 83735 | <1% | 6,140 | $33K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,212 | $33K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 857 | $32K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 789 | $29K |
| 84439 | <1% | 3,918 | $28K | |
| 80164 | <1% | 3,246 | $23K | |
| 84481 | <1% | 2,663 | $22K | |
| 81001 | <1% | 9,502 | $22K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,041 | $21K |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 14,552 | $21K |
| 83540 | <1% | 3,235 | $17K | |
| 84153 | <1% | 1,371 | $15K | |
| 87088 | <1% | 1,692 | $14K | |
| 83880 | <1% | 708 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 292 | $12K |
| 82728 | <1% | 1,959 | $12K | |
| 80177 | <1% | 1,569 | $12K | |
| 86038 | <1% | 918 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 291 | $11K |
| 80185 | <1% | 1,143 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,369 | $11K |
| 86141 | <1% | 763 | $11K | |
| 86140 | <1% | 2,556 | $10K | |
| 85651 | <1% | 2,347 | $9K | |
| 87040 | <1% | 435 | $8K | |
| 86706 | <1% | 666 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 276 | $7K |
| 85730 | <1% | 1,355 | $7K | |
| 86803 | <1% | 549 | $7K | |
| 82140 | <1% | 794 | $6K | |
| 86060 | <1% | 848 | $6K | |
| 81003 | <1% | 3,281 | $6K | |
| 87077 | <1% | 2,390 | $5K | |
| 82552 | <1% | 908 | $5K | |
| 84100 | <1% | 1,621 | $5K | |
| 87340 | <1% | 428 | $5K | |
| 82150 | <1% | 879 | $5K | |
| 84550 | <1% | 1,356 | $4K | |
| 86430 | <1% | 873 | $4K | |
| 83970 | <1% | 157 | $4K | |
| 87070 | <1% | 830 | $4K | |
| 80076 | <1% | 788 | $4K | |
| 86592 | <1% | 1,096 | $4K | |
| 82043 | <1% | 1,039 | $4K | |
| 80202 | <1% | 267 | $3K | |
| 80074 | <1% | 101 | $3K | |
| 85652 | <1% | 1,224 | $3K | |
| 86696 | <1% | 147 | $3K | |
| 83550 | <1% | 410 | $2K | |
| 86695 | <1% | 158 | $2K | |
| 82570 | <1% | 531 | $2K | |
| 87493 | <1% | 64 | $2K | |
| 80050 | General health panel | <1% | 62 | $2K |
| 84134 | <1% | 300 | $2K | |
| 80299 | <1% | 170 | $1K | |
| 87899 | <1% | 144 | $1K | |
| 86735 | <1% | 119 | $1K | |
| 87205 | <1% | 412 | $1K | |
| 84145 | <1% | 75 | $1K | |
| 86762 | <1% | 118 | $920.98 | |
| 80156 | <1% | 124 | $895.45 | |
| 86765 | <1% | 118 | $847.19 | |
| 84132 | <1% | 315 | $758.79 | |
| 85379 | <1% | 150 | $733.67 | |
| 86376 | <1% | 91 | $727.86 | |
| 86710 | <1% | 26 | $606.21 | |
| 82550 | <1% | 118 | $579.61 | |
| 80047 | <1% | 114 | $565.89 | |
| 85014 | <1% | 253 | $468.08 | |
| 82950 | <1% | 112 | $445.55 | |
| 84703 | <1% | 69 | $410.15 | |
| 87486 | <1% | 17 | $406.22 | |
| 87184 | <1% | 24 | $362.63 | |
| 84466 | <1% | 73 | $356.81 | |
| 82565 | <1% | 121 | $353.56 | |
| 81015 | <1% | 958 | $348.64 | |
| 85044 | <1% | 151 | $320.54 | |
| 83655 | <1% | 30 | $288.30 | |
| 84520 | <1% | 111 | $253.16 | |
| 82310 | <1% | 66 | $192.35 | |
| 85009 | <1% | 105 | $156.33 | |
| 80184 | <1% | 16 | $133.66 | |
| 84295 | <1% | 63 | $129.14 | |
| 82274 | <1% | 12 | $108.71 | |
| 82374 | <1% | 43 | $91.03 | |
| 84436 | <1% | 14 | $88.69 | |
| 82435 | <1% | 45 | $85.38 | |
| 85018 | <1% | 50 | $82.39 | |
| 85048 | <1% | 44 | $56.77 | |
| 85004 | <1% | 457 | $52.77 | |
| 84460 | <1% | 25 | $43.32 | |
| 82947 | <1% | 16 | $42.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAHMAD, IMTIAZ (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Gondal Medical Care P.C. | Brooklyn, NY | $1.57M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.